Investigation of systems to prevent diversion of opiate drugs in general practice in the UK

Quality and Safety in Health Care

Volumn 13, Issue 1, 2004, Pages 21-25

  Baker, R ^a   Moss, P ^a   Upton, D ^b   Pankhania, J ^b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b DE MONTFORT UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

OPIATE AGONIST;

ARTICLE; CONFUSION; CONTROLLED STUDY; DATA ANALYSIS; DRUG MONITORING; DRUG STORAGE; GENERAL PRACTICE; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH SERVICE; HUMAN; INTERVIEW; MEDICAL ASSESSMENT; MEDICAL INFORMATION; QUESTIONNAIRE; UNITED KINGDOM;

DRUG AND NARCOTIC CONTROL; ENGLAND; FAMILY PRACTICE; HEALTH SERVICES RESEARCH; HUMANS; INTERVIEWS; NARCOTICS; QUESTIONNAIRES;

EID: 1242306666     PISSN: 14753898     EISSN: None     Source Type: Journal    
DOI: 10.1136/qshc.2002.002485     Document Type: Article

References (14)

1. Department of Health, Welsh Office, Scottish Home and Health Department. Guide to the Misuse of Drugs Act 1971 and the Misuse of Drugs Regulations. London: Department of Health, 1989.
2. Anonymous. Drugs for the doctor's bag revisited. Drug Ther Bull 2000;38:65-8.
3. Forgione DA, Neuenschwander P, Vermeer TE. Diversion of prescription drugs to the black market: what the states are doing to curb the tide. J Health Care Finance 2001;27:65-78.
4. Fountain J, Strang J, Gossop M, et al. Diversion of prescribed drugs by drug users in treatment: analysis of the UK market and new data from London. Addiction 2000;95:393-406.
5. Johnson DE, Ryan KM, Gilson AM, et al. Trends in medical use and abuse of opioid analgesics. JAMA 2000;283:1710-4.
6. Rajagopal MR, Joranson DE, Gilson AM. Medical use, misuse, and diversion of opioids in India. Lancet 2001;358:139-43.
7. Baker R. Harold Shipman's Clinical Practice 1974-1998. London: The Stationery Office, 2001 (available at www.gov.uk/hshipmanpractice).
8. Mohr JJ, Batalden PB. Improving safety on the front lines: the role of clinical microsystems. Qual Saf Health Care 2002;11:45-50.
9. Institute of Medicine. Why do errors happen? In: To err is human. Building a safer health system. Washington, DC: National Academy Press, 2000:49-68.
10. Sajan A, Corneil T, Grzybowski S. The street value of prescription drugs. Can Med Assoc J 1998;159:139-42.
11. Simoni-Wastila L, Tompkins C. Balancing diversion control and medical necessity: the case of prescription drugs with abuse potential. Substance Use Misuse 2001;361275-361296.
12. Joranson DE, Gilson AM. Pharmacists' knowledge of and attitudes towards opioid pain medications in relation to federal and state policies. J Am Pharm Assoc 2001;41:213-20.
13. Department of Health. Building a safer NHS for patients. London: Department of Health, 2001 (available at www.npsa.org.uk).
14. Department of Health. An organisation with a memory. Report of an expert group on learning from adverse events in the NHS, chaired by the Chief Medical Officer. London: Department of Health, 2000.